Background: The study evaluated nano structured extract Morinda citrifolia L. (Noni) conveyed in enteral form, in an experimental model
of intestinal ischemia/reperfusion (I/R), as well as in the prevention of bacterial translocation.
Purpose: Observe the protective and repairing effect of Noni’s
nanoemulsified extract in the presence of induced bacterial
translocation,
by an experimental model of intestinal ischemia/reperfusion.
Methods and Findings: The study consisted of 2 groups of 7
animals, where the Controls were treated with 0.9% saline solution (I/R +
S) and Experimental group (I/R + Noni) treated with 5 mg/ml/Kg Noni
nanoemulsion, orally by gavage 12h and 2h before the experiment.
In the groups, the superior mesenteric artery was occluded with a
vascular micro clamp and the laparotomy reopened 60min. after for pull
back the clamp. Treatment response was assessed by blood count,
inflammatory markers and biochemical dosages, including a sample of the
terminal ileum and hepatic of each animal was harvested, fixed in
formalin 10% and included in paraffin and stained with hematoxylin-eosin
for morphometric measurement. Measurement of TNF-α, IL-1β, IL-6, and
IL-10 was done. One gram of spleen, liver, and mesenteric lymph
nodes were harvested for culture by selective means for Gram (-) and
Gram (+) bacteria. ANOVA and the post-hoc Turkey and Student´s t test
were used, considering p<0, 05 as significant.
Conclusion: Noni´s nanoemulsion positively influenced the
organic reactions in the presence of intestinal ischemia/reperfusion,
reducing
the production of pro inflammatory cytokines, bacterial translocation,
preventing tissue injury and attenuating the systemic inflammatory
response against the experimental model used
Keywords: Noni: Ischemia-reperfusion injury; Bacterial translocation; Biotechnology; Nanotechnology; phytotherapy
Abbreviations: GGT: Gamma-glutamyl
Transferase; ECUA: Ethics Committee on the Use of Animals; NCCAE:
National Council for Control of
Animal Experimentation; NO: Nitric oxide; AST: glutamic-oxalacetic
transaminase; ALT: glutamic-pyruvic transaminase; HSV: total bilirubin
and
fractions, erythrocyte sedimentation rate; SMA: Superior Mesenteric
Artery
Mammography
Intestinal ischemia-reperfusion (I-R) injury is a severe
condition resulting from acute mesenteric ischemia, small bowel
transplantation, abdominal aortic aneurysm, hemorrhage, trauma,
septic shock, or severe burns. Various chemical and cellular
mediators have been implicated in the pathogenesis of intestinal
ischemia/reperfusion, such as reactive oxygen, cytokines, endotoxins, and neutrophils [1]. Following adhesive interactions
among neutrophils and endothelial cells, neutrophil accumulation
in the intestinal mucosa contributes to intestinal ischemia/
reperfusion injury via production of reactive oxygen metabolites
and proteases. Leukocyte accumulation is a complex phenomenon
that also involves endothelium-based adhesion molecules as well
as leukocyte chemotaxis factors such as interleukin-8 (IL-8) [2,3].
Intercellular adhesion molecules are normally expressed at a
low basal level, but their expression can be enhanced by several
inflammatory cytokines such as IL-1β and tumour necrosis factor-α
(TNF-α). A variety of cytokines, including TNF-α, interferon-γ, and
IL-1β, are released from post-ischemic tissues [4].
It is now considered that these mediators bring about the
systemic microcirculatory injury which is thought to be the main
mechanism responsible for damage in sepsis. The host defence
responses to sepsis may promote the generalized increase in
leukocyte recruitment and accumulation in the tissues, which
may lead to subsequent endothelial damage, leaky capillaries,
and organ dysfunction and failure [5,6]. The organic lesion begins
in the lungs, progressing to the anguish respiratory syndrome,
followed by kidney and liver failure because of damage caused by
the architecture of these organs. Heart failure occurs in late-stage
sepsis [7]. The pathophysiology of intestinal ischemia/reperfusion
(I/R) in rats with induction of bacterial translocation is widely used
in animal models and well established in the literature, and is a
viable way of analyzing therapeutic options [8].
The technique will result in a bacterial translocation, generating
an ideal model for the therapeutic trial with Noni. Medicinal plants
influence the health conditions of the people, in part due to the
increase of studies with phytotherapeutics, leading to a confirmation
of the therapeutic action of several popular plants, a fact that
proves Phytotherapy as part of the culture of the population, being
used and widespread for many generations[9-11]. In Brazil, the use
of medicinal herbs has its bases in the indigenous practice, which
influenced by the African and Portuguese culture, generated a vast
popular culture. With the technological advances in allopathic
medicine and the pharmaceutical industry in recent years, herbal
medicines have been placed in the background, being something
allied to popular belief and without scientific bases [12]. However,
due to side effects and the high cost of medicines, Phytotherapy is
again highlighted and scientific studies with medicinal plants are
being resumed [13].
Among the species for herbal treatment highlights the Morinda
citrifolia L. (Rubiaceae), popularly known as Noni. Information
on its therapeutic benefits has gone through the world causing
great demand as a medicinal product [14-16]. Morinda citrifolia L
(Noni) has the phytotherapeutic activity of analgesic, antimicrobial,
antitumor, anti-inflammatory and antioxidant effects. In scientific
studies conducted for the isolation of fixed compounds of the plant,
about 200 active substances have already been isolated, where the
presence of anthraquinones, triterpenes, iridoids, among others [7-
9]. The anti-inflammatory activity of Noni has been studied in vivo and
in vitro by inhibiting the activity of COX-1 enzymes and COX-
2, and the release of chemical mediators from macrophages (nitric
oxide (NO) and prostaglandin E2 - PGE-2)[10].
In this sense, products using biotechnology in the form of
nanoparticles or nanostructured compounds, can have excellent
results, since, due to their reduced diameter, the substance can
be used in smaller doses, avoiding the toxic effect of the plant and
maintaining its phytotherapic action [11-13]. Thus, the objective of
the present study was to evaluate the protective and repairing effect
of Noni’s nanoemulsified extract in the presence of induced bacterial
translocation, by an experimental model of intestinal ischemia/
reperfusion (I/R) in rats, using the dosage and subsequent blood
count, inflammatory markers and biochemical measurements,
including histopathological analysis of the compared to the control
group treated with 0.9% saline solution.
Material and Methods
Ethical Principles
The experimental protocol was approved by the Ethics
Committee on the Use of Animals - ECUA, number 012/2016,
Brazil. Animals were handled in accordance with the Guide for the
Care and Use of Laboratory Animals, US National Research Council,
1996. The Institutional Committee on Ethics in the Use of Animals
approved the research project under the protocol. The care with
the use of the animals followed the standards of the Brazilian
legislation for the scientific use of animals (Law 11.794 / 2008
National Council for Control of Animal Experimentation - NCCAE /
Brazilian Government).
Preparation of vegetable extract hydroalcoholic extract
of Morinda citrifolia L: (Noni)
The hydroalcoholic extract of Morinda citrifolia L. was prepared
from the aerial parts (stem, leaves, and fruits) of fresh adult plants.
The collected material was placed for drying at room temperature;
then comminuted with a knife and placed for 24h in an oven at a
temperature between 45ºC and 50ºC to remove moisture. It was
then subjected to a grinding process to obtain the powder. This
material was weighed and deposited in a glass vessel with the
addition of 70% hydroalcoholic solution in the ratio of 1:3 of the
powder. The resulting mixture was stirred for 12h and stirred
for five minutes every two hours under two simple filtration
procedures under reduced pressure to give the crude extract, which
was concentrated in a rotary evaporator under reduced pressure, at
a temperature between 55°C and 60°C, for total solvent elimination.
The product obtained after concentration was in the form of a paste
which was diluted in distilled water until a hydroalcoholic extract
at the concentration of 5mg/ml was obtained, being kept in a
refrigerator at 10ºC until it was used.
Obtaining Nanoemulsified Systems
Nanoemulsion systems were obtained by maceration in a
mixture of ethanol: water (8:2/800mL of alcohol 70° INPM +
200mL of distilled water) according to the previously described methodology. The study of phase diagrams of the oil, water and
surfactant mixture formed a nanoemulsified (SN) system with a
self-emulsifying characteristic. The SN system was considered
O/W of the autoemulsifying type due to the unchanging of its
appearance after successive dilutions in water. The vegetable oil
used contains the following chemical components: vitamin E,
oleic, linoleic and linolenic acid, low saturated fat and high content
of polyunsaturated components [17,18]. The procedure used to
obtain the nano emulsion regions is based on the method involving
the determination of the maximum solubility points of active
matter (surfactant) in the aqueous and oily phases, by means of
mass titrations. The structure is composed of vegetable oil in the
range of 0.5% to 6.0%; a surfactant in the range of 8.0% to 20% and
distilled water in the range of 75% to 90% (Figure 1).
Figure 1: Phase Diagram (Maciel 2009).
Description of Nanoemulsion Preparation: Initially,
industrialized vegetable oil was weighed on a precision digital
scale (model: FA-2104N / 2008; Brand: BIOPRECISA-->) in the
preferred range (1% to 5%), the surfactant in the preferred range
(8% to 20%), and distilled water in the preferred range (75% to
90%) mixed and heated the components of the formulated SME -
Nanoemulsion System, in magnetic stirrer with heating - stirring
range 100-2200rpm and temperature controlled in the preferred
range between 40°C to 70°C (Model NI1103P/2009: Mark:
NOVAINSTRUMENTS-->). Thereafter, centrifuged at a constant
speed, between 550rpm and 650rpm, for a preferential time of 15
minutes. (Model TDL80-2B, Mark Centribio-->).
Analysis Characterization: Performed through the refractive
index, droplet diameter, rheological behavior and surface tension.
To obtain the refractive index, an analog bench refractometer
(ABBE, Model: 2waj; Mark: BioBrix-->) was used at a temperature
in the range of 20°C-30°C.
Determination of droplet diameter: The diameter of the
nanoemulsion droplets was determined by measurements in
triplicates and with the refractive index of 1.4715 with a light beam
of 659nm wavelength and angle of incidence of 90°. The diameter
of the droplets (ranged from 50nm-75nm).
Rheology: The evaluation made from the graph generated by
shear stress versus shear rate using a greenhouse thermometer (HG -
Brazil, No.1876/11-->), in the range of 20°C-30°C, with variation
for the shear rate (1s-1-1000s-1), resulted in a linear behaviour,
with r2 = 0.91058.
Fluid Classification: The fluid under analysis was classified as
Newtonian and the viscosity was determined to be 2mPa.s - 6mPa.s
(2cP - 5cP).
Maximum Dilution Analysis: The evaluation was performed
by experimental data of surface tension. Assays were performed
using the SensaDyne Tensiometer apparatus (model QC-600,
Chem-Dyne Research Corp. - USA). The description of the method
consisted of measuring the maximum bubble pressure using two
capillaries with holes of different diameters, where an inert gas
(N2) was pumped at a certain constant pressure (200-595kPa). The
larger capillary measured the effect of the immersion depth and the
smaller the surface tension. For each measurement, the samples
were diluted in distilled water, with concentrations varying until
the values of surface tension close to the water (γH2O = 72.1mN/m)
and temperature in the range of 20°C to 30°C were reached.
Surgical model / experimental design: We used 14 Wistar
male Wistar rats weighing 265±32g (from Nucleus of Experimental
Surgery, Potigura Universty - LAUREATE INTERNATIONAL
UNIVERSITIES - UnP/Natal/Rio Grande do Norte State/ Brazil),
randomly divided into 2 groups, kept in individual cages with food
and water standard (Labina-Purina-->) is rodents, ad libitum. In the
experimental group (n=7) rats received 5mg/mL/Kg (EMS-FC5)
Noni nanoemulsion via the probe/gavage 18 and 2 hours prior to
clamping of the superior mesenteric artery (I/R), the remainder
rats (n=7) were treated with oral saline solution at 0.9%, 18 and 2h
prior to (I/R). After 12h of fasting, the rats were anesthetized with
for the induction of anesthesia general, the solution of Zoletil--> 50,
the anesthetic dissociative, will be used in the dose of 0.3mL/100mg
intramuscularly in the region of the quadriceps, with disposable
syringes of 1mL of insulin and needle 27F and operated under
aseptic conditions. In groups I/R + Saline and I/R + Noni, under
sterile conditions.
Measurement of bacterial translocation: After shaving,
the abdominal skin was disinfected with 0.2% chlorhexidine. All
procedures were performed under sterile conditions. A laparotomy
was performed and the superior mesenteric artery (SMA) was
occluded with a microvascular clamp for 60 minutes. In order
to block any collateral blood supply, the right colic and proximal
jejunal arteries were also clamped. The laparotomy incision was
then closed, to be opened later for removal of the clamps after 60
minutes of ischemia. Reperfusion was confirmed by the return of
the mesenteric arcade pulsation. The incision was closed again and
the animals were killed by anesthetic overdose (thiopental 100mg/
Kg) after 120 minutes of reperfusion. They breathed spontaneously
throughout the procedures.
Measurement of bacterial translocation: At the end of
the procedures (time = 180 minutes), a midline laparotomy was
performed under aseptic conditions and biopsies were aseptically
obtained for bacterial colony counts. One gram of mesenteric lymph node complex, blood, liver, and lung were removed for
culture. Tissues were homogenized and aseptically solubilized after
addition of 0.5mL of 0.9% saline. Aliquots of 0.2mL were processed
and cultured on selective MacConkey’s agar and Blood Agar for
detection of gram-negative and gram-positive bacteria, respectively.
The agar plates were incubated at 37oC and examined for growth
after 24 and 48h. Any growth in the plates of bacteria of the same
biotype as cultured was considered positive and expressed as
colony-forming units per gram of tissue (CFU/g).
Laboratory analysis/ Cytokine Assays: After 24h of a
conclusion of the procedures under anesthesia and aseptic
conditions, blood was collected by cardiac puncture to measure
the hemogram, hepatogram, cytokines, and albumin. Samples
of blood were treated with EDTA and the plasma was separated
by centrifugation at 2000rpm and stored in -80°C for later
measurement of tumor necrosis factor (TNF-a) interleukin-6
(IL-6) and interleukin- 1b (IL-1b) by the ELISA (enzyme-linked
all immunoassay kits from PeproTech--> (Rocky Hill, NJ, USA)
according to the manufacturer’s recommended protocols. The
fluorescence was measured by a Bio-Tec--> Instruments EL808 ultra
microplate reader, using KC4-V3.0 analysis software. The sensitivity
of detection was 30pg/mL for all cytokines. For counting leukocytes
and red cells using an automated cell counter (Abbott Cell-Dyn
3500R CD--> 5L-3500, USA). For albumin, alkaline phosphatase,
gamma-glutamyl transferase (GGT), glutamic-oxalacetic
transaminase (AST), glutamic-pyruvic transaminase (ALT), total
bilirubin and fractions, erythrocyte sedimentation rate (HSV) blood
was treated with EDTA.
Histological study: Terminal ileum and liver specimens were
fixed in 10% buffered formalin and embedded in paraffin. Sections
cut at a thickness of 4μm were stained with hematoxylin and eosin
for morphometric measurements using an image analyzer (Image-
Pro Plus, Media Cyber-->)[19-21]. The damage of the intestinal
specimens was assessed in a blinded manner by an experienced
pathologist according to microscopic criteria for degree of damage
based on a grading system previously described: normal mucosa, 0;
subepithelial space at the villus tip, 1; more extended subepithelial
space, 2; epithelial lifting along villus, 3; denuded villi, 4; loss of
villus tissue, 5; crypt layer infarction, 6; transmucosal infarction, 7;
transmural infarction, 8.
Statistics: Data analysis was performed using the BioEstat-->
2.0 program. Differences between the microbiological samples
as measured by positive cultures were evaluated by a test for
differences between proportions. The results were tabulated
and compared by ANOVA using post hoc analysis with Tukey
and Student’s t test. P<0.05 was considered significant. Data on
continuous quantitative variables are the mean ± expresso standard
deviation. In the variables that did not present normal distribution,
the logarithmtransformation method was adopted. These variables
are represented by their respective logarithms. To verify if the
differences between the Experimental (Noni nanoemulsion) and
Control groups were statistically significant, the Student’s t-test for
independent samples was used. The statistical package SPSS-->21
was used.
Results
We observed bacterial translocation to mesenteric lymph nodes,
liver, lung, and blood in all animals subjected to I / R. However, in
I/R group rats treated with Noni nanoemulsion, translocation
to these organs and blood was significantly lower than in I/R
untreated (Table 1). Cytokines had lower levels of proinflammatory
cytokines in group I/R+Noni (TNF-α, IL-1β, IL-6) and a higher
level of antiinflammatory-cytokine (IL-10), when compared with
I/R + Saline (C) (Table 2). In I/R + Saline (Control) group rats, the
levels of pro-inflammatory cytokines were significantly higher
when compared to I/R+Noni. This group had the highest values
of IL-10 when compared with (Control) group (p<0.05). Noni was
able to maintain and modulate the inflammatory reaction in the
experimental group, which was proven through normality in the
hematological dosages. There was also a significant reduction in
the number of total leukocytes, which did not generate immune
suppression in experimental animals, but control the systemic
inflammatory response in the presence of induced bacterial
translocation for intestinal ischemia and reperfusion.
Table 1: Bacterial Translocation in groups treated and not
treated with Noni nanoemulsion (colony-forming units per gram of tissue -
CFU/g).
*p < 0.01 compared with groups I/R + Saline (C) and I/R + Noni nanoemulsion.
Table 2: Serum levels of cytokines in groups with and without Noni nanoemulsion treatment.
*p< 0.01 compared with groups I/R + Saline (C) and I/R + Noni nanoemulsion.
Table 3: Descriptive and inferential statistics of hemograma results.
Figure 2: The mucosa is injured, and leukocyte infiltration of lamina propria and mucosa are shown (group I/R), 100x. 2:
Hemorrhage and inflammation of mucosa (group I/R), 100x.
A trend towards normality was observed in the other cellular
parameters measured in relation to the control group (Table 3).
Macroscopically, the segments of the organs studied presented
intramural dilation and hemorrhage, with greater intensity in
rats of the I / R group, compared to the experimental group
(Noni). Microscopic findings revealed marked mucosal lesion after
ischemia and reperfusion injury; we observed more intense lesions
in the rats of the I / R group compared to the other groups. The
most frequent lesions were: disorganization of the normal tissue
structure, transmural infarction, infiltration of leukocytes in the
lamina propria and mucosa, alveoli and hepatic sinusoids. In the
group that used the nanoemulsion of Noni, there was protection
and preservation of the tissue structure, with reduced or absent
infiltrating inflammatory reaction (Figures 2-4).
Figure 3: Preserved intestinal mucosa, demonstrating
normal villi and intestinal epitelial cells of uniform pattern,
normal to histological examination, 100x
Figure 4: A) Normal liver structures are demonstrated. B) A hepatic section from a septic rat with vehicle (normal saline)
treatment. Patches of hepatocytes show necrosis with eosinophilic cytoplasm nuclei that are condensed and intensely stained
with hematoxylin. C: A section from a septic rat with Morinda citrifolia L (Noni) treatment. Liver structures appear normal.
(HE.50;100 x /100 μm).
Discussion
The present study used an experimental model of ischemia
and reperfusion, to verify the effect of nanostructured extract
Morinda citrifolia L. (Noni) on intestinal injury and bacterial
translocation. Some authors consider the bacterial factor, crucial
in the pathogenesis of sepsis and multiple organ failures [22]. In
surgery and intensive care, intestinal obstruction and intestinal
ischemia are the most associated pathological conditions [23].
The use of medicinal plants for the treatment of diseases has
been occurring since the dawn of civilization. The development of
methodologies for the isolation of active substances has made it
possible to identify substances in complex samples such as plant
extracts. In this way, the interest for compounds of vegetal origin
that could be used as prototypes for the development of new drugs
resurfaced [24]. Medicinal plants represent the main raw material
used for the synthesis of medicinal products, besides being used as
therapeutic agents. Plant consumption is overvalued in traditional
use based on it medicinal benefits [25].
Noni (Morinda citrifolia L.) has become a promise of the cure for
a variety of diseases, ranging from simple hypertension to malignant
tumors; even provokes the cure of syndromes, still incurable such
as AIDS and other viral diseases [26]. However, The popular use
and wellbeing attributed to Noni make the industry commercially
explore Morinda citrifolia L products, often without scientific
evidence [15].In this context, the use of biotechnology transforming
Noni into a nanostructured compound, has the advantage of using
the plant’s medicinal properties, reducing its toxicity, keeping its
bioactive principles beneficial to health [27,28]. Antimicrobial
activity of Noni has already been reported in the literature. Studies
have shown that noni inhibited growth in vivo and in-vitro bacterial
strains such as Staphylococcus aureus, Pseudomonas aeruginous,
Bacillus subtilis, Escherichia coli, Helicobacter pylori, Salmonella
and Shigella.
In addition, Noni has already been studied on its effect against
Plasmodium falciparum, believed to be due to the presence of anthraquinones, acubin, L-asperuloside, alizarin, scopoletin,
among other substances [29,30]. It has also been found that ethanol
and hexane extracts of noni have an antitubercular effect since they
inhibit by 89-95% the growth of Mycobacterium tuberculosis. The
major components identified in the hexane extract were E-phytol,
cycloartenol, stigmasterol, b-sitosterol, campesta-5,7,22-trien-3-bol,
and the ketosteroids, stigmasta-4-en-3-one and stigmasta-4-22-
dien-3-one[18-20]. Moreover, they showed that the anti-microbial
effect is highly dependent on the stage of ripeness and on processing,
being greater when the fruit is ripe, without drying [23-25]. The
limiting factor for the use of Noni as an herbal remedy is that most
of the studies previously found in the literature, administer the
extract in the alcoholic or hydro-alcoholic form, which may, through
prolonged use, mainly cause hepatotoxicity [24].
With this in mind, the present study makes its scientific
contribution to demonstrate that with the use of biotechnology in the
formulation of a nanostructured extract of Noni, such undesirable
side effects were abolished, maintaining the active principles of the
vegetable under analysis [31]. Recent studies have demonstrated,
respectively, the efficiency of Noni´s nanoemulsion in experimental
models of healing of infected wounds in the skin of rats as well as in
abdominal sepsis induced by cecum ligation and puncture [32,33].
This phenomenon was confirmed in the present study, where a
reduction in the total leukocytes and polymorphonuclear levels
was observed, maintaining normal hemoglobin and hematocrit
levels in the experimental group, which used Noni in the presence
of an experimental model of intestinal ischemia/reperfusion (I/R)
in rats with induction of bacterial translocation.
Conclusion
In conclusion, the present study demonstrated that Noni’s
nanoemulsified extract acted as an immune modulatory agent in
the presence of an experimental model of intestinal ischemia/
reperfusion (I/R) in rats with induction of bacterial translocation,
reducing the systemic inflammatory response, stimulating
the immunity of experimental group animals, preserving liver function and maintaining its bioactive principles beneficial to the
experimental model used.
Read More Lupine Publishers Research & Reviews Journal Please click on below link
https://lupinepublishers.blogspot.com/